Clinical Trial Update: The Influence of Timing of Cabergoline Initiation on Prevention of OHSS [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether the timing of cabergoline initiation affects the prevention of ovarian hyperstimulation syndrome; the study status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• Dostinex (cabergoline)

Snippet

Sponsor: Mona M Shaban | Conditions: Ovarian Hyperstimulation Syndrome | Phase 3 | Status: UNKNOWN